Aurobindo Pharma Ltd (AUROPHARMA) — Announcement | 11 September 2026(5 announcements)

Aurobindo Pharma announced its participation in an investor meeting with ICICI Securities on September 17, 2026, from 2:30 to 3:30 PM IST in Hyderabad, confirming no UPSI will be discussed.

Aurobindo Pharma announced its participation in the Kotak Healthcare Forum investor meeting on September 18, 2026, in Mumbai, offering one-on-one and group sessions with company officials. The filing confirms no unpublished price sensitive information will be discussed, and the schedule remains subject to change. This event provides investors direct access to management ahead of potential strategic updates.

Aurobindo Pharma announced its participation in an investor meeting hosted by Emkay Global on September 17, 2026, from 10:00 AM to 11:00 AM IST in Hyderabad, confirming attendance without disclosing any unpublished price sensitive information.

Aurobindo Pharma announced its participation in the Bank of America Asia Pacific Conference on September 21, 2026, from 9:00 AM to 5:00 PM HKT in Hong Kong, offering one-on-one and group meetings with investors and analysts. The filing confirms no unpublished price sensitive information will be discussed during the event. This meeting provides a platform for the company to engage with global investors and analysts, potentially influencing market perception and interest ahead of upcoming financial updates.

Aurobindo Pharma announced its participation in a J. P. Morgan investor conference on September 22, 2026, in Mumbai, offering one-on-one and group meetings with company officials. The filing confirms the event details and location but does not disclose any financial results, guidance, or material changes. This routine investor engagement provides analysts and shareholders a chance to discuss the company's pipeline and growth strategy without revealing new price-sensitive data.